Chris Lau

Chris Lau

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why You Shouldn’t Count Qualcomm, Inc. (QCOM) Stock Out Just Yet

QCOM stock has a few catalysts heading its way. These include Samsung powering its latest Galaxy S8 with a Qualcomm Snapdragon chip and an impending deal with NXP.

BlackBerry Ltd. (BBRY) Stock Is Ready for Launch After Qualcomm Win

BlackBerry (BBRY) followed a strong earnings report with a big-dollar arbitration win against Qualcomm. Expect BBRY stock to keep rallying.

7 Tech Stocks That Are a Sneeze Away From Collapsing

Stretched valuations are becoming the norm for tech stocks, and these stocks to sell could be brought down by a single hiccup.

Why AT&T Inc. (T) Stock Should Weather the Internet Privacy Storm

AT&T stock is stuck in the middle of the internet privacy controversy, but given its strong dividend and FirstNet contract, the stock should remain strong.

Bank of America Corp (BAC) Stock Faces a Growing Bear Threat

Bank of America (BAC) is down after Friday's weak jobs put a cap on rate-hike hopes. But don't forget the convincing bull story in BAC stock.